Accelerating injectables formulation development
Join Citeline and Thermo Fisher Scientific for expert perspectives on:
- Solutions for poor solubility, dissolution and compound sensitivities
- Guiding development with DOE modelling, analytical characterization, and risk-based approaches
- Best practices for lyophilization, viscosity reduction, and managing high-concentration biologics
- Designing non-GMP studies to fast-track first-in-human (FIH) trials
Meet the Speakers
Christy Eatmon
Global Steriles SME,
Thermo Fisher Scientific, Pharma Services Group
Alessandro Chreim
Global Steriles SME,
Thermo Fisher Scientific, Pharma Services Group
Liji Joseph
Process Development Lead,
Thermo Fisher Scientific, Pharma Services Group
Fill out the form to watch on demand now!
By completing this form you agree Citeline and Thermo Fisher Scientific Inc. may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Thermo Fisher Scientific Inc
Inspire. Connect. Innovate.
